HIV molecular immunology database
Found 1 matching record:
HXB2 Location | Gag(77-85) | Gag Epitope Map
View variants at this location |
||||
---|---|---|---|---|---|---|
Epitope |
SLYNTVATL
|
Epitope Alignment | ||||
Variants |
|
|||||
Epitope Name | SL9 | |||||
Species (MHC/HLA) | human(A2) |
Showing 1 of 11 variants.
Variant ID. | 3239 |
---|---|
Epitope Seq. | SLYNTVATL |
Variant Seq. | SLYNTiATL |
Mutations | V/I |
Epitope Location | V6I |
HXB2 Location | V82I |
Mutation Type | OV: observed variant |
Method | Chromium-release assay, HLA binding |
Note | Natural 6I variant SLYNTiATL, was found in patients 9300868 and 241. Variant peptide bound HLA-A*02 at a relative binding of 114% compared to SL9 index peptide. Lysis of CTL lines occurs at all concentrations of peptide tested. |
Sewell1997 A. K. Sewell, G. C. Harcourt, P. J. Goulder, D. A. Price, and R. E. Phillips. Antagonism of Cytotoxic T Lymphocyte-Mediated Lysis by Natural HIV-1 Altered Peptide Ligands Requires Simultaneous Presentation of Agonist and Antagonist Peptides. Eur. J. Immunol., 27:2323-2329, 1997. PubMed ID: 9341776. Show all entries for this paper.